Proteomics technology has revealed that ANXA1 mainly regulates the processes related to tumour cell skeletal remodelling and immune responses, thus affecting the invasive migration of cancer cells (Tu et al., 2017). This evidence concerns the gene ANXA1 and neoplasm.